journal article·2020-07Open access

Bio-inspired apatite particles limit skin penetration of drugs for dermatology applications

Maëla Choimet, Audrey Tourrette, Olivier Marsan, Giovanna Rassu, Christophe Drouet

Acta Biomaterialia· Volume 111
Publisher page

Abstract

Most treatments of skin pathologies involve local administration of active agents. One issue can however be the partial transcutaneous diffusion of the drug to blood circulation, leading to undesirable effects. In this work, the original use of submicron mineral particles based on bio-inspired calcium phosphate apatite was explored for the first time as drug carriers for favoring topical delivery. The permeation of a model drug across synthetic and biological membranes was investigated in both static and dynamic conditions. Our data show that adsorption of the drug on the apatite particles surface drastically limits its permeation, with lower effective diffusion coefficients (Peff) and smaller total released amounts. The retention of the apatite colloidal particles on porcine ear skin explants surface was demonstrated by combining histological observations and Raman confocal microscopy. All results converge to show that association of the drug to apatite particles favors skin surface effects. These findings point to the relevance of mineral-based particles as drug carriers for local delivery to the skin, and open the way to novel applications of bio-inspired apatites in dermatology. STATEMENT OF SIGNIFICANCE: Calcium phosphates (CaP) are major biomaterials in orthopedics and dentistry. Their resemblance to bone mineral allows new applications beyond bone repair, e.g. in nanomedicine. In 2018, a 14-page detailed review (M. Epple, Acta Biomaterialia 77 (2018) 1-14) provided clear facts in favor of the non-toxicity of nanosized CaP as an answer to discussions from EU and US study groups, thus clarifying the path to novel applications of nano CaP. In the present paper, bio-inspired apatite nanoparticles are used for the first time as drug carriers for dermatology for drastically limiting drug transcutaneous permeation and retaining a topical effect. We demonstrate this proof of concept via permeation cell tests, histology, Raman microscopy and photoluminescence after application on porcine ear skin.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advancements in Transdermal Drug Delivery · Contact Dermatitis and Allergies · Acne and Rosacea Treatments and Effects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Treatment of acne vulgaris10.1016/j.paed.2010.09.012 ↗
2. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy10.1080/00015550310016463 ↗
3. Topical acne drugs: review of clinical properties, systemic exposure, and safety10.2165/00128071-200304070-00004 ↗
4. Targeting to the hair follicles: current status and potential10.1016/j.jdermsci.2009.12.005 ↗
5. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin10.1038/sj.jid.5700226 ↗
6. Selective follicular targeting by modification of the particle sizes10.1016/j.jconrel.2010.11.015 ↗
7. The antimicrobial activity of liposomal lauric acids against Propionibacterium acnes10.1016/j.biomaterials.2009.07.033 ↗
8. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris10.1038/jid.2009.93 ↗
9. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne10.1080/02652040701288519 ↗
10. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles10.1016/j.ijpharm.2009.07.025 ↗
11. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne10.1007/s00403-011-1130-3 ↗
12. Ultrasonic delivery of silica-gold nanoshells for photothermolysis of sebaceous glands in humans: Nanotechnology from the bench to clinic10.1016/j.jconrel.2015.03.004 ↗
13. Development of Smart Semisolid Formulations to Enhance Retinoic Acid Topical Application10.1002/jps.24612 ↗
14. Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents–I. Intercalation and in vitro release of ibuprofen10.1016/S0378-5173(01)00629-9 ↗
15. Progress on the preparation of nanocrystalline apatites and surface characterization: Overview of fundamental and applied aspects10.1016/j.pcrysgrow.2012.11.001 ↗
16. Apatite nanoparticles strongly improve red blood cell cryopreservation by mediating trehalose delivery via enhanced membrane permeation10.1016/j.biomaterials.2017.06.018 ↗
17. Nanocrystalline apatites: a versatile functionalizable platform for biomedical applications for bone engineering... and beyond10.4028/www.scientific.net/KEM.696.14 ↗
18. Nanomedicine: Interaction of biomimetic apatite colloidal nanoparticles with human blood components10.1016/j.colsurfb.2016.04.038 ↗
19. Biomimetic apatite-based functional nanoparticles as promising newcomers in nanomedicine: overview of 10 years of initiatory research
20. Novel contributions on luminescent apatite-based colloids intended for medical imaging10.1177/0885328212473510 ↗
21. Biomimetic nanocrystalline apatites: Emerging perspectives in cancer diagnosis and treatment10.1016/j.ijpharm.2011.07.005 ↗
22. Transfection of cells with custom-made calcium phosphate nanoparticles coated with DNA10.1039/b401644k ↗
23. Europium-doped bioapatite: A new photostable biological probe, internalizable by human cells10.1016/S0142-9612(03)00169-8 ↗
24. Purification of biomimetic apatite-based hybrid colloids intended for biomedical applications: a dialysis study10.1016/j.colsurfb.2010.09.022 ↗
25. Evaluation of the effect of hydroxypropyl-beta-cyclodextrin on topical administration of milk thistle extract10.1016/j.carbpol.2012.09.018 ↗
26. Interaction of folic acid with nanocrystalline apatites and extension to methotrexate (antifolate) in view of anticancer applications10.1021/acs.langmuir.8b02602 ↗
27. Strat-M® synthetic membrane: Permeability comparison to human cadaver skin10.1016/j.ijpharm.2018.06.012 ↗
28. Cossu · 2019
29. Preparation and physicochemical characteristics of luminescent apatite-based colloids10.1021/jp910923g ↗
30. Surface properties of biomimetic nanocrystalline apatites; applications in biomaterials10.1016/j.pcrysgrow.2014.09.005 ↗
31. Bestimmung der Größe und der inneren Struktur von Kolloidteilchen mittels Röntgenstrahlen, Nachrichten von der Gesellschaft der Wissenschaften zu Göttingen
32. Biomimetic apatite-based biomaterials: on the critical impact of synthesis and post-synthesis parameters
33. Apatite formation: why it may not work as planned, and how to conclusively identify apatite compounds10.1155/2013/490946 ↗
34. In vitro skin models as a tool in optimization of drug formulation10.1016/j.ejps.2015.02.018 ↗
35. Prediction of skin permeation by chemical compounds using the artificial membrane, Strat-M10.1016/j.ejps.2014.11.002 ↗
36. Solid microparticles based on chitosan or methyl-beta-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate10.1016/j.jconrel.2015.01.025 ↗
37. Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses
38. Emerging treatment options in atopic dermatitis: topical therapies10.1159/000484407 ↗
39. A systematic review of adverse effects associated with topical treatments for psoriasis
40. An update on the role of the sebaceous gland in the pathogenesis of acne10.4161/derm.3.1.13900 ↗
41. Bone mineral: update on chemical composition and structure10.1007/s00198-009-0860-y ↗
42. Colloidal apatite particles: a multifunctional platform in (nano)medicine
43. Skin models for the testing of transdermal drugs